Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
ModeX Therapeutics, An OPKO Health Company
ModeX Therapeutics, An OPKO Health Company
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Stanford University
Adela, Inc
ITM Solucin GmbH
Turning Point Therapeutics, Inc.
St. Jude Children's Research Hospital
Mayo Clinic
Memorial Sloan Kettering Cancer Center
AIDS Malignancy Consortium
Essen Biotech
Children's Oncology Group
University Health Network, Toronto
Lantern Pharma Inc.
Ruijin Hospital
Presage Biosciences
Karolinska University Hospital